Simmons Bank’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.01M | Sell |
57,449
-437
| -0.8% | -$23.1K | 0.17% | 124 |
|
|
2026
Q1 | $3.19M | Sell |
57,886
-2,636
| -4% | -$143K | 0.21% | 109 |
|
|
2025
Q4 | $2.97M | Buy |
60,522
+161
| +0.3% | +$7.51K | 0.2% | 112 |
|
|
2025
Q3 | $2.61M | Buy |
60,361
+3,148
| +6% | +$123K | 0.17% | 126 |
|
|
2025
Q2 | $2.2M | Buy |
57,213
+1,443
| +3% | +$55.1K | 0.16% | 132 |
|
|
2025
Q1 | $2.16M | Sell |
55,770
-95,552
| -63% | -$3.5M | 0.16% | 128 |
|
|
2024
Q4 | $5.12M | Sell |
151,322
-1,997
| -1% | -$71.9K | 0.37% | 71 |
|
|
2024
Q3 | $6.27M | Buy |
153,319
+4,630
| +3% | +$189K | 0.45% | 61 |
|
|
2024
Q2 | $5.72M | Buy |
148,689
+4,871
| +3% | +$205K | 0.43% | 61 |
|
|
2024
Q1 | $6.17M | Buy |
143,818
+5,104
| +4% | +$210K | 0.46% | 55 |
|
|
2023
Q4 | $5.14M | Buy |
138,714
+4,130
| +3% | +$148K | 0.42% | 62 |
|
|
2023
Q3 | $4.88M | Buy |
134,584
+364
| +0.3% | +$12.9K | 0.43% | 61 |
|
|
2023
Q2 | $4.78M | Buy |
134,220
+3,312
| +3% | +$119K | 0.4% | 72 |
|
|
2023
Q1 | $4.66M | Buy |
130,908
+23,445
| +22% | +$820K | 0.4% | 70 |
|
|
2022
Q4 | $3.78M | Buy |
+107,463
| New | +$3.58M | 0.32% | 81 |
|
|
2021
Q2 | – | Sell |
-19,454
| Closed | -$868K | – | 375 |
|
|
2021
Q1 | $868K | Sell |
19,454
-973
| -5% | -$44.2K | 0.07% | 222 |
|
|
2020
Q4 | $940K | Sell |
20,427
-14,056
| -41% | -$646K | 0.07% | 204 |
|
|
2020
Q3 | $1.62M | Sell |
34,483
-4,765
| -12% | -$239K | 0.13% | 149 |
|
|
2020
Q2 | $2M | Buy |
39,248
+4,941
| +14% | +$253K | 0.17% | 125 |
|
|
2020
Q1 | $1.63M | Buy |
34,307
+16,262
| +90% | +$867K | 0.14% | 125 |
|
|
2019
Q4 | $1.06M | Sell |
18,045
-520
| -3% | -$28.9K | 0.1% | 178 |
|
|
2019
Q3 | $990K | Sell |
18,565
-384
| -2% | -$19.8K | 0.1% | 180 |
|
|
2019
Q2 | $948K | Sell |
18,949
-484
| -2% | -$24.3K | 0.09% | 185 |
|
|
2019
Q1 | $1.01M | Buy |
19,433
+164
| +0.9% | +$8.2K | 0.1% | 178 |
|
|
2018
Q4 | $921K | Buy |
19,269
+1,120
| +6% | +$55.2K | 0.1% | 164 |
|
|
2018
Q3 | $911K | Buy |
18,149
+240
| +1% | +$12.2K | 0.09% | 170 |
|
|
2018
Q2 | $902K | Sell |
17,909
-800
| -4% | -$40.3K | 0.08% | 184 |
|
|
2018
Q1 | $914K | Sell |
18,709
-120
| -0.6% | -$5.59K | 0.08% | 175 |
|
|
2017
Q4 | $835K | Sell |
18,829
-5,563
| -23% | -$257K | 0.08% | 170 |
|
|
2017
Q3 | $1.24M | Sell |
24,392
-820
| -3% | -$41.6K | 0.13% | 138 |
|
|
2017
Q2 | $1.36M | Sell |
25,212
-680
| -3% | -$36.3K | 0.15% | 127 |
|
|
2017
Q1 | $1.36M | Sell |
25,892
-2,641
| -9% | -$134K | 0.15% | 122 |
|
|
2016
Q4 | $1.37M | Sell |
28,533
-2,861
| -9% | -$141K | 0.15% | 127 |
|
|
2016
Q3 | $1.69M | Sell |
31,394
-68
| -0.2% | -$3.73K | 0.19% | 110 |
|
|
2016
Q2 | $1.7M | Sell |
31,462
-906
| -3% | -$47.7K | 0.19% | 107 |
|
|
2016
Q1 | $1.64M | Buy |
+32,368
| New | +$1.61M | 0.18% | 111 |
|
Other funds holding GSK
JEST
Simmons Bank's GSK Position: Q2 2026 in Review
Simmons Bank reduced its GSK (GSK) stake by 0.75% in Q2 2026, selling an estimated $23.1K and leaving 57,449 shares worth $3.01M. The position accounts for 0.17% of the portfolio, ranked #124.
Simmons Bank first reported a position in GSK in Q1 2016 and has held it in 36 quarters since. The position peaked at $6.27M in Q3 2024. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Simmons Bank held 57,449 shares of GSK worth $3.01M as of Q2 2026.
- Simmons Bank sold 437 GSK shares in Q2 2026, an estimated $23.1K.
- GSK made up 0.17% of Simmons Bank's portfolio in Q2 2026, its #124 holding.
- Simmons Bank first reported a position in GSK in Q1 2016 and has held it in 36 quarters since.
- Simmons Bank's GSK position peaked at $6.27M in Q3 2024.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Simmons Bank's 13F filing for Q2 2026, filed 31 Jul 2026.